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Salvage antegrade visceral revascularization
and antegrade aortic stenting for type I and III
endoleaks after fenestrated juxtarenal
aneurysm repair
Manjit S. Gohel, MD, FRCS, FEBVS,a,b Martin Clark, FRCR,c Elika Kashef, FRCR,c and
Richard G. J. Gibbs, MD, FRCS,d Cambridge and London, United Kingdom
A 73-year-old man developed type I and III endoleaks from a fractured right renal stent with downward migration of a
fenestrated endograft, 6 years after endovascular repair of a juxtarenal aneurysm. Endovascular treatment attempts were
unsuccessful. He underwent aortic debranching and antegrade visceral artery revascularization via a left thoracolaparot-
omy incision and an extraperitoneal approach to the visceral aorta. An antegrade aortic stent covered the endoleak, with
technical and clinical success at 9 months. Failure of complex endografts presents particular problems, potentially not
amenable to totally endovascular repair. Continued surveillance is mandated as late, asymptomatic sac expansion can

































sTotal endovascular repair of hostile necked infrarenal,
juxtarenal,1 and thoracoabdominal2-4 aortic aneurysms us-
ing custom-made fenestrated, scalloped, and branched
stents is becoming increasingly popular with advances in
expertise and stent technology. Reasonable short- to mid-
term results have been reported. Type I and III endoleaks
reportedly occur after around 18% of complex endovascular
procedures,5 and their management can be technically
challenging. We present a case of a patient with type I and
III endoleaks after fenestrated stent graft repair, treated
with antegrade open visceral revascularization and stenting
following failed endovascular rescue.
CASE REPORT
A 68-year-old male patient presented in 2005 with a 59-mm
juxtarenal aortic aneurysm. He had previously undergone an ante-
rior resection for colorectal carcinoma with anastamotic leak and
eight subsequent laparotomies and end-ileostomy, and was left
with a hostile abdomen. He also had myelodysplasia (with throm-
bocytopenia) and chronic kidney disease with an estimated glo-
merular filtration rate of 45. Despite 6-mm external iliac arteries,
an endovascular approach was felt to offer the safest solution.
He underwent an endovascular repair via an iliac conduit using
a custom-made stent graft (Cook Medical Inc, Bloomington, Ind)
with renal fenestrations and a scallop for the superior mesenteric
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he left renal artery and an uncovered stent (Bard Medical, Cov-
ngton, Ga) was deployed in the right renal artery.
He entered post-endovascular aneurysm repair (EVAR) sur-
eillance with annual computerized tomography (CT) scanning,
nd the sac size remained static until 2011, when he was asymp-
omatic, but noted to have a rapidly enlarging aortic sac diameter,
ncreasing from 59 to 76 mm associated with type I and III
ndoleaks (Fig 1). The endograft had tilted and migrated distally
econdary to right renal stent fracture. Two attempts to cannulate
he right renal artery through the fractured stent were unsuccessful
Fig 2). Proximal extension of the aortic stent to cover the en-
oleaks would have also required coverage of the visceral arteries.
ollowing multidisciplinary team review and extensive discussion
ith the patient and family, the decision was made to proceed with
combined open and endovascular procedure.
Using a left thoracolaparotomy incision and extraperitoneal
pproach (in view of the presumed extensive intraperitoneal adhe-
ions), antegrade 8-mm bifurcated Dacron grafts were taken from
he mid-descending thoracic aorta and anastomosed on to the
eliac axis and superior mesenteric artery with a 6-mm jump graft
o the left renal artery, which were subsequently ligated at their
rigins. Grafts were tunneled through the diaphragm in a peri-
ortic plane. A 34-mm diameter, 100-mm length stent (Talent
aptivia; Medtronic, Minneapolis, Minn) was then delivered in an
ntegrade fashion (via a 10-mm conduit sewn onto the origin of
he hybrid grafts) and deployed to cover both renal stents and
xtend into the distal thoracic aorta. A preoperative decision was
ade to sacrifice the right renal artery. Balloon molding was
voided to reduce the risk of fabric tearing from the fractured renal
tent and postdeployment angiography revealed no evidence of
ndoleak and patent grafts. Following a short stay in the intensive
are unit, the patient made an excellent recovery and was dis-
harged from hospital on day 16 (with a delay to organize social
upport at home). Prior to discharge, CT angiography demon-




s at year 6 with significant sac expansion.
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accessory renal artery and the postoperative renal function re-
mained essentially unchanged, with an estimated glomerular filtra-
tion rate of 42 at 6 months. Subsequent surveillance CT at 9
months shows a stable sac size with no evidence of endoleak.
DISCUSSION
Endovascular solutions are considered preferable to
open repair for many complex aortic pathologies, although
the long-term durability of fenestrated and branched
custom-made stents is unclear. Under surveillance, a novel
and challenging set of complications are being identified in
this patient group. Estimates of type I and III endoleaks
following fenestrated stent grafting range from 3% to
Fig 2. Attempted cannulation of fractured right renal stent.
Fig 1. New type I and III endoleak18.6%.6 Secondary procedures for complications have a rig 3. Computerized tomography (CT) demonstrating ante-
rade arrangement of celiac, superior mesenteric artery, and left
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Volume 56, Number 6 Gohel et al 1733high failure rate, although the 3-year freedom from any
device-related secondary procedure is around 75.5%.5 We
have successfully treated type III endoleaks after fenestrated or
branched stent grafting with visceral artery restenting or
using a vascular plug to occlude the origin of a discon-
nected visceral stent. Other endovascular strategies such as
the use of chimney stents and partial occlusion of visceral
origins with patent foramen ovale closure devices have been
reported.7 In this case, type I and III endoleaks were
identified 5 years after fenestrated EVAR causing a signifi-
cant increase in aortic sac diameter. No endovascular treat-
ment options were successful, and a hybrid solution was
considered the most appropriate management option. Al-
though the patient had significant comorbidities and had a
slightly worse health status than at the time of the original
fenestrated EVAR, this more invasive intervention was
deemed preferable to conservative management when
faced with a rapidly enlarging aortic sac. It is important to
note that the long-term risks of fenestrated EVAR were
poorly understood at the time of the original intervention
for this patient. However, even with the current, improved
understanding of the risk of late endoleaks after complex
EVAR procedures,8 it is unlikely that current management
would differ significantly from 6 years ago. Some authors
have reported the potential benefits of thrombin injection
or sac embolization for the treatment of endoleaks,9,10
although the value of these options in the presence of a
high-pressure endoleak was considered to be limited in this
case.
Visceral revascularization is most commonly performed
using a retrograde technique, from the distal aorta or iliac
arteries. Antegrade revascularization has been described
from the ascending aorta, but the descending aorta is an
uncommon site from which to take grafts. In this case, the
extensive previous abdominal surgery (and intraperitoneal
sepsis) precluded a transperitoneal approach. The totally
extraperitoneal approach to the abdominal aorta is well
described, but has significant limitations. First, the right
renal artery is not accessible from the left approach and
access to the celiac and superior mesenteric arteries is
limited in comparison to the transperitoneal approach.
Despite these limitations, the totally extraperitoneal expo-
sure and antegrade revascularization offers a useful option,
particularly in patients with a hostile abdomen or unsuit-
able iliac vessels. In this case, the exposure was adequate to
permit comfortable visceral artery access, whereas this may
not be the case in patients with obesity or less favorable
anatomy. SThis case exemplifies the need for long-term follow-up
n patients with aortic stent grafts. The renal artery stent
racture and subsequent tilting and migration of the endo-
ascular device caused a rapid sac expansion, which re-
ained asymptomatic and was only identified on annual
urveillance. The stent graft failure occurred suddenly 6
ears after implantation. This case also highlights that late
ignificant endoleaks arising after complex EVAR may not
e amenable to endovascular repair, meaning that special-
sts involved in the management of this patient group
hould have the expertise to offer complex open as well as
ndovascular reinterventions.
The increasing popularity of complex endovascular
reatments for aortic aneurysms is likely to mean that vas-
ular specialists will encounter a greater number of unique
nd challenging complications. Optimal management may
nvolve endovascular, open and hybrid treatment options
nd should be offered by a multidisciplinary team in a
igh-volume institution.
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